161 related articles for article (PubMed ID: 37858622)
41. Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics.
Chamarthy S; Mekala JR
Metab Brain Dis; 2023 Jun; 38(5):1441-1469. PubMed ID: 37093461
[TBL] [Abstract][Full Text] [Related]
42. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
[TBL] [Abstract][Full Text] [Related]
43. Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools.
Valdebenito S; D'Amico D; Eugenin E
Cancer Rep (Hoboken); 2019 Dec; 2(6):e1220. PubMed ID: 32729241
[TBL] [Abstract][Full Text] [Related]
44. SUMOylation in Glioblastoma: A Novel Therapeutic Target.
Fox BM; Janssen A; Estevez-Ordonez D; Gessler F; Vicario N; Chagoya G; Elsayed G; Sotoudeh H; Stetler W; Friedman GK; Bernstock JD
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991648
[TBL] [Abstract][Full Text] [Related]
45. Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme.
Mu L; Han Z; Yu S; Wang A; Chen D; Kong S; Gu Y; Xu L; Liu A; Sun R; Long Y
Front Immunol; 2022; 13():842524. PubMed ID: 36618381
[TBL] [Abstract][Full Text] [Related]
46. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.
Wang R; Zhang S; Chen X; Li N; Li J; Jia R; Pan Y; Liang H
Mol Cancer; 2018 Nov; 17(1):166. PubMed ID: 30470262
[TBL] [Abstract][Full Text] [Related]
47. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
[TBL] [Abstract][Full Text] [Related]
48. Role of Post-translational Modifications in Alzheimer's Disease.
Ramesh M; Gopinath P; Govindaraju T
Chembiochem; 2020 Apr; 21(8):1052-1079. PubMed ID: 31863723
[TBL] [Abstract][Full Text] [Related]
49. Post-translational modifications: Regulators of neurodegenerative proteinopathies.
Gupta R; Sahu M; Srivastava D; Tiwari S; Ambasta RK; Kumar P
Ageing Res Rev; 2021 Jul; 68():101336. PubMed ID: 33775891
[TBL] [Abstract][Full Text] [Related]
50. ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma.
Lailler C; Louandre C; Morisse MC; Lhossein T; Godin C; Lottin M; Constans JM; Chauffert B; Galmiche A; Saidak Z
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467175
[TBL] [Abstract][Full Text] [Related]
51. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
Li J; Li L; You P; Wei Y; Xu B
Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
[TBL] [Abstract][Full Text] [Related]
52. The DNA methylome of glioblastoma multiforme.
Martinez R; Esteller M
Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
[TBL] [Abstract][Full Text] [Related]
53. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
Kabir F; Apu MNH
Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
[TBL] [Abstract][Full Text] [Related]
54. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
55. Enhanced Global Post-translational Modification Discovery with MetaMorpheus.
Solntsev SK; Shortreed MR; Frey BL; Smith LM
J Proteome Res; 2018 May; 17(5):1844-1851. PubMed ID: 29578715
[TBL] [Abstract][Full Text] [Related]
56. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
57. A Novel MKL Method for GBM Prognosis Prediction by Integrating Histopathological Image and Multi-Omics Data.
Zhang Y; Li A; He J; Wang M
IEEE J Biomed Health Inform; 2020 Jan; 24(1):171-179. PubMed ID: 30763249
[TBL] [Abstract][Full Text] [Related]
58. Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5.
Feng X; Zhang H; Meng L; Song H; Zhou Q; Qu C; Zhao P; Li Q; Zou C; Liu X; Zhang Z
Autophagy; 2021 Mar; 17(3):723-742. PubMed ID: 32186433
[TBL] [Abstract][Full Text] [Related]
59. The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression.
Ni B; Huang G; Yang R; Wang Z; Song H; Li K; Zhang Y; Wu K; Shi G; Wang X; Shen J; Liu Y
J Neuroinflammation; 2023 Mar; 20(1):80. PubMed ID: 36944954
[TBL] [Abstract][Full Text] [Related]
60. An update on the epigenetics of glioblastomas.
Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N
Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]